16 December 2025
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
Stemtech Corp
CIK: 1511820•2 Annual Reports•Latest: 2025-06-30
10-K / June 30, 2025
Revenue:$5,053,690
Income:-$3,772,701
10-K / July 10, 2024
Revenue:$4,921,531
Income:-$5,430,245
10-K / June 30, 2025
Company Summary: Stemtech Corporation
Business Overview
-
Type of Business:
Global network marketing company focused on developing science-based wellness products, particularly related to stem cell science. -
Core Product Focus:
Supports wellness by helping the body maintain healthy stem cell physiology through stem cell enhancers. These products aim to:- Release the body’s own stem cells
- Promote circulation of stem cells in the blood
- Facilitate migration of stem cells into tissues for renewal and repair
-
Product Attributes:
- Products are all-natural, plant-based botanicals.
- Do not contain actual stem cells but support their natural function.
- Marketed as Stem Cell Nutrition™, with products like the RCM System, stemrelease3™, StemFlo®, MigraStem®, OraStem®, and skincare lines like Cellect One® Night Cream and Shield HOCL.
-
Market & Distribution:
- Marketed internationally via subsidiaries and independent distributors.
- Primary channels include an independent distributor (IBP) network and direct-to-consumer (DTC) retail model.
- Plans to expand with new products like StemPets™ for pets, targeting the $303 billion global pet industry.
Financial and Operational Details
-
Employees & Customers:
Specific number of employees and customers not provided. -
Revenue & Income:
- 2024 Revenue: Approximately $5,053,690
- 2023 Revenue: Approximately $4,921,531
- 2024 Net Loss: $3,772,701 (improved from $5,431,979 in 2023)
- 2023 Net Loss: $5,431,979
-
Additional Business Information:
- The company emphasizes expanding its independent distributor network, projecting the addition of 30,000 new IBPs over 12-24 months.
- Operates on a network marketing model combining international subsidiaries, independent distributors, and direct-to-consumer sales.
- The company has been recognized four times in the Inc 5000 list of fastest-growing companies.
Regulatory & Corporate Details
- Legal & Regulatory:
- Noted ongoing legal proceedings related to unpaid salary claims.
- The company is a Nevada-incorporated entity, with a fiscal year-end changed to December 31, as of November 2021.
- Market trading symbol: STEK (OTCQB market).
- Total shares outstanding as of June 30, 2025: 142,443,444 shares.
Strategic Focus
- Reinforce product offerings and expand the distributor network.
- Introduce new products to increase market penetration, including pet and skincare lines.
- Aspire to grow revenues and move toward profitability while managing substantial net losses and a significant accumulated deficit.
- Focus on global expansion and leveraging a flexible, network-driven distribution strategy.
